Programmatic rollout of longacting injectable cabotegravir (CAB PrEP) has launched in Zambia and Zimbabwe! Recommended by the World Health Organization as a safe and effective HIV prevention method in 2022, these two countries are now the first in Africa to incorporate this new, longawaited PrEP product into their national HIV prevention programs. In the short time that local partners have been delivering CAB PrEP in Zambia and Zimbabwe, they have gained important insights into what it takes to prepare for and successfully integrate CAB PrEP as an additional HIV prevention option. In this webinar, Ministry of Health leaders and partners from Zambia and Zimbabwe reflected on their early implementation experience and shared critical learnings for other countries poised to introduce CAB PrEP this year.

05:50 Preparing for CAB PrEP introduction | Florence Mulenga, FHI 360 Zambia
18:30 Early experiences with CAB introduction in Zambia | Tina Chisenga, Zambia Ministry of Health
35:55 Early experiences with CAB introduction in Zimbabwe | Getrude Ncube, Zimbabwe Ministry of Health and Child Care
53:10 Audience Q&A